ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BYOT Byotrol Plc

0.10
-0.025 (-20.00%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Byotrol Plc LSE:BYOT London Ordinary Share GB00B0999995 ORDS 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.025 -20.00% 0.10 0.05 0.15 0.125 0.075 0.125 7,964,210 16:07:23
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Chemicals & Chem Preps, Nec 4.59M -1.69M -0.0037 -0.27 453.89k

Byotrol PLC Appointment of CFO & Award of Options (2020A)

28/05/2019 7:01am

UK Regulatory


Byotrol (LSE:BYOT)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Byotrol Charts.

TIDMBYOT

RNS Number : 2020A

Byotrol PLC

28 May 2019

28 May 2019

Byotrol plc

("Byotrol", or the "Company")

Appointment of Chief Financial Officer

Award of Options

Byotrol plc, the AIM quoted anti-microbial technology company, is pleased to announce the appointment of Nic Hellyer as CFO and Executive Director of the Company with immediate effect.

Nic is a Chartered Accountant (FCA) and former investment banker with over 25 years' corporate finance experience, mostly at UBS and HSBC, managing corporate development, M&A and fund raisings for growth and entrepreneurial companies (both public and private).

He is being employed on a part-time basis by the Company alongside his other business interests, which include a part-time CFO role at Pelatro plc, another AIM-listed company.

The Company has today granted Nic Hellyer options over 2,000,000 shares under the Byotrol plc approved share option scheme at a strike price of 2.6p. These options are exercisable in three tranches from 28 May 2020, 2021 and 2022 subject to the Company's share price reaching hurdles of 3.5p, 5.5p and 7.5p.

At the date of this announcement, Mr Hellyer does not have any other beneficial interest in the ordinary shares of the Company.

In addition to the above, the Company is issuing a further 1,000,000 shares to a new employee under the Byotrol plc share option scheme, on the same terms as detailed above.

John Langlands, Chairman of the Company, said,

"We are delighted to welcome Nic to the Board of the Byotrol. He has a wealth of experience from his time in the investment banking world, including extensive experience in the smaller company environment, and has directly relevant experience as a Finance Director for an SME on AIM. His skills will be invaluable to us as we continue to grow and develop Byotrol."

 
 
   Current directorships and/or partnerships     Former directorships and/or 
   of Nicholos James Hellyer (56):               partnerships (within the last 
                                                 five years): 
 Defenx plc                                    The Marketing Group plc 
  Pelatro Plc 
  Reeflive Limited 
  Weyland-Yutani Property Management 
  Limited 
 

Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

Enquiries:

Byotrol plc 01925 742 000

John Langlands - Chairman

David Traynor - Chief Executive

finnCap Ltd 020 7220 0500

Geoff Nash / Kate Bannatyne - Corporate Finance

Richard Chambers - ECM

Notes to Editors:

Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of antimicrobial technologies, identifying, developing, formulating and commercialising cutting-edge antimicrobial solutions.

Our patented suite of technologies deliver powerful, broad-spectrum efficacy, optimised against commonly-occurring and industry-specific pathogens.

Founded in 2005, the Company seeks to develop and commercialise advanced antimicrobial technologies that create easier, safer and cleaner lives for everyone.

For more information, please go to www.byotrol.co.uk

Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):

 
        1.   Details of the person discharging managerial responsibilities 
              / person closely associated 
 a)          Name                             Nic Hellyer 
            -------------------------------  -------------------------------------- 
        2.   Reason for the Notification 
            ----------------------------------------------------------------------- 
 a)          Position/status                  Chief Financial Officer 
            -------------------------------  -------------------------------------- 
 b)          Initial notification/Amendment   Initial 
            -------------------------------  -------------------------------------- 
 3.          Details of the issuer, emission allowance market participant, 
              auction platform, auctioneer or auction monitor 
            ----------------------------------------------------------------------- 
 a)          Name                             Byotrol Plc 
            -------------------------------  -------------------------------------- 
 b)          LEI                              213800AJMTSTIPA59A34 
            -------------------------------  -------------------------------------- 
 4.          Details of the transaction(s): section to be repeated 
              for (i) each type of instrument; (ii) each type of transaction; 
              (iii) each date; and (iv) each place where transactions 
              have been conducted 
            ----------------------------------------------------------------------- 
 a)          Description of the               options over ordinary shares of 0.25p 
              Financial instrument,            each 
              type of instrument 
             Identification code              GB00B0999995 
            -------------------------------  -------------------------------------- 
 b)          Nature of the transaction        Award of Options to subscribe for 
                                               Ordinary Shares 
            -------------------------------  -------------------------------------- 
 c)          Price(s) and volume(s)           Volume - 2,000,000 
                                               Exercise Price - 2.6 pence 
            -------------------------------  -------------------------------------- 
 d)          Aggregated information:          See 4(c) above 
            -------------------------------  -------------------------------------- 
 e)          Date of the transaction          28 May 2019 
            -------------------------------  -------------------------------------- 
 f)          Place of the transaction         Outside of a trading venue 
            -------------------------------  -------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCPGUCUAUPBGMC

(END) Dow Jones Newswires

May 28, 2019 02:01 ET (06:01 GMT)

1 Year Byotrol Chart

1 Year Byotrol Chart

1 Month Byotrol Chart

1 Month Byotrol Chart

Your Recent History

Delayed Upgrade Clock